LOS ANGELES, June 07, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ra Medical Systems, Inc. (“Ra Medical” or “the Company”) (NYSE: RMED) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Ra Medical’s initial public offering (“IPO”) was completed in September 2018, and involved the sale of approximately 4.5 million shares at $17.00 per share. The Company admitted on March 14, 2019, that its fourth quarter 2018 financial results failed to reach its targets due to issues including the hiring and training of sales staff, among other problems. Based on this news, shares of Ra Medical fell by more than 32% on March 15, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm 
Brian Schall, Esq. 
310-301-3335
Cell: 424-303-1964
info@schallfirm.com

www.schallfirm.com